1. Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer
   Christina S. Baik et al, 2015, Journal of Thoracic Oncology CrossRef
2. Prevalence and risk factors of brain metastases in patients with newly diagnosed advanced non-small-cell lung cancer
   T. Duell et al, 2015, Cancer Treatment Communications CrossRef
3. Histopathologic analysis of brain metastasis in pulmonary adenocarcinoma: Necrosis is a new risk factor
   Binnari Kim et al, 2019, Pathology - Research and Practice CrossRef
4. Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival
   Kolja Pocha et al, 2020, Clinical Cancer Research CrossRef
5. Agile delivery of protein therapeutics to CNS
   Xiang Yi et al, 2014, Journal of Controlled Release CrossRef
6. Neurological Complications of Lung Cancer
   Ming Chi et al, 2018, Cancer Neurology in Clinical Practice CrossRef
7. Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma
   Chang-shuai Zhou et al, 2021, OncoTargets and Therapy CrossRef